Align Technology Announces China Food and Drug Administration Approval for the iTero Element Intraoral Scanner

SAN JOSE, Calif., April 25, 2018 -- Align Technology, Inc. (NASDAQ:ALGN) today announced that the company has received approval from the China Food and Drug Administration (CFDA) to market the iTero Element intraoral scanner in China.

“The market opportunity in China is huge and it remains the single largest country market for Align outside of the United States,” said Julie Tay, Align Technology senior vice president and managing director, Asia Pacific. “The Chinese intraoral scanner market is less than two percent penetrated today and is expected to grow 6X by 2020. Not only does the iTero Element scanner launch support the growth of our base Invisalign clear aligner business, but it also represents a major milestone for digital dentistry in China. We’re glad to take a leadership role bringing the latest and most advanced intraoral scanning technologies to the region.”

About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign^® system, the most advanced clear aligner system in the world, and iTero^® intraoral scanners and services. Align's products help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about iTero digital scanning system, please visit www.itero.com.